Sign in|Subscribe
ImaiGlobal News & AI Updates
Breaking
Studiocanal Unveils First Look at Fred Cavayé's Epic 'Les Misérables' Adaptation·GKIDS Secures Studio Ghibli UK/Ireland Rights, 'Kiki's Delivery Service' Set for IMAX Debut·Weird Al Yankovic Rejects Lucrative AI Commercial: 'I Can't Be the Poster Boy'·Harry Kane Sets Unwanted World Cup Record in England's Clash with Mexico·Gary Glitter Faces New Historic Sexual Offense Charges from 1970s·Peyton Manning’s Omaha Productions Expands Into Women’s Sports Content·Norway's Historic World Cup Ascent: How Erling Haaland is Defining a New Era·VAR Controversy Erupts: Mexico and England Clash in Dramatic Football Showdown·Studiocanal Unveils First Look at Fred Cavayé's Epic 'Les Misérables' Adaptation·GKIDS Secures Studio Ghibli UK/Ireland Rights, 'Kiki's Delivery Service' Set for IMAX Debut·Weird Al Yankovic Rejects Lucrative AI Commercial: 'I Can't Be the Poster Boy'·Harry Kane Sets Unwanted World Cup Record in England's Clash with Mexico·Gary Glitter Faces New Historic Sexual Offense Charges from 1970s·Peyton Manning’s Omaha Productions Expands Into Women’s Sports Content·Norway's Historic World Cup Ascent: How Erling Haaland is Defining a New Era·VAR Controversy Erupts: Mexico and England Clash in Dramatic Football Showdown·Studiocanal Unveils First Look at Fred Cavayé's Epic 'Les Misérables' Adaptation·GKIDS Secures Studio Ghibli UK/Ireland Rights, 'Kiki's Delivery Service' Set for IMAX Debut·Weird Al Yankovic Rejects Lucrative AI Commercial: 'I Can't Be the Poster Boy'·Harry Kane Sets Unwanted World Cup Record in England's Clash with Mexico·Gary Glitter Faces New Historic Sexual Offense Charges from 1970s·Peyton Manning’s Omaha Productions Expands Into Women’s Sports Content·Norway's Historic World Cup Ascent: How Erling Haaland is Defining a New Era·VAR Controversy Erupts: Mexico and England Clash in Dramatic Football Showdown·
Back

Tagged

AI Drug Discovery

Takeda’s $600 Million Gamble: How the Insilico Partnership Redefines the AI Drug Discovery Race
LLM News & AI Tech

Takeda’s $600 Million Gamble: How the Insilico Partnership Redefines the AI Drug Discovery Race

Takeda Pharmaceutical has inked a massive $600 million deal with Insilico Medicine to leverage the Pharma.AI platform. This strategic move aims to bypass the traditional bottlenecks of drug discovery, promising to cut years off development timelines and billions off research budgets.

Jul 4, 2026